Molecule Details
InChIKeyLNEPOXFFQSENCJ-UHFFFAOYSA-N
Compound NameHaloperidol
Canonical SMILESO=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
Clinical Status Clinical Multi-Target
Targets (Human+Pathogen)33
Pfam Stratification Cross-Family
Avg pChEMBL7.13
SourceBindingDB;ChEMBL;TTD_MultiTarget
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB00502
Drug NameHaloperidol
CAS Number52-86-8
Groups approved investigational
ATC Codes N05AD01
DescriptionHaloperidol is a high potency first-generation (typical) antipsychotic and one of the most frequently used antipsychotic medications used worldwide.[A180616] While haloperidol has demonstrated pharmacologic activity at a number of receptors in the brain,[A27477] it exerts its antipsychotic effect th...

Categories: Agents that reduce seizure threshold Anti-Dyskinesia Agents Antidepressive Agents Antiemetics Antipsychotic Agents Antipsychotic Agents (First Generation [Typical]) Autonomic Agents Butyrophenone Derivatives Butyrophenones Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP1A1 Substrates Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 CYP2C19 Substrates Cytochrome P-450 CYP2C9 Substrates Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (moderate) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 CYP3A7 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Dopamine Agents Dopamine Antagonists Dopamine D2 Receptor Antagonists Drugs causing inadvertant photosensitivity Drugs that are Mainly Renally Excreted Gastrointestinal Agents Hyperglycemia-Associated Agents Ketones Moderate Risk QTc-Prolonging Agents NMDA Receptor Antagonists Nervous System Neurotoxic agents Neurotransmitter Agents P-glycoprotein inhibitors P-glycoprotein substrates Peripheral Nervous System Agents Photosensitizing Agents Psycholeptics Psychotropic Drugs QTc Prolonging Agents Serotonin 5-HT1 Receptor Antagonists Serotonin 5-HT1A Receptor Antagonists Serotonin 5-HT2 Receptor Antagonists Serotonin 5-HT2A Receptor Antagonists Serotonin 5-HT2C Receptor Antagonists Serotonin Agents Serotonin Receptor Antagonists Tranquilizing Agents UGT1A9 Substrates
Cross-references: BindingDB: 50019951 ChEBI: 5613 CHEMBL54 ChemSpider: 3438 Drugs Product Database (DPD): 10146 Guide to Pharmacology: 86 IUPHAR: 86 C01814 D00136 PDB: GMJ PharmGKB: PA449841 PubChem:3559 PubChem:46508794 RxCUI: 5093 Therapeutic Targets Database: DAP000313 Wikipedia: Haloperidol ZINC: ZINC000000537822
Target Activities (33)
Target Gene Organism Category Pfam pChEMBL Type Source
P14416 DRD2 Homo sapiens Human PF00001 8.8 Ki ChEMBL;BindingDB
Q99720 SIGMAR1 Homo sapiens Human PF04622 8.5 Ki ChEMBL;BindingDB
P35462 DRD3 Homo sapiens Human PF00001 8.3 Ki ChEMBL;BindingDB
P21917 DRD4 Homo sapiens Human PF00001 8.3 Ki ChEMBL;BindingDB
P35348 ADRA1A Homo sapiens Human PF00001 8.2 pIC50 TTD_MultiTarget
P35368 ADRA1B Homo sapiens Human PF00001 8.0 Ki ChEMBL
Q5BJF2 TMEM97 Homo sapiens Human PF05241 7.7 Ki ChEMBL;BindingDB
P28335 HTR2C Homo sapiens Human PF00001 7.6 Ki ChEMBL;BindingDB
P41595 HTR2B Homo sapiens Human PF00001 7.6 Ki ChEMBL;BindingDB
P25100 ADRA1D Homo sapiens Human PF00001 7.6 Ki ChEMBL
Q12809 KCNH2 Homo sapiens Human PF00027 PF00520 PF13426 7.5 IC50 ChEMBL;BindingDB
P28221 HTR1D Homo sapiens Human PF00001 7.4 Ki BindingDB
P21918 DRD5 Homo sapiens Human PF00001 7.3 Ki ChEMBL;BindingDB
P21728 DRD1 Homo sapiens Human PF00001 7.1 Ki ChEMBL;BindingDB
P28223 HTR2A Homo sapiens Human PF00001 7.0 Ki ChEMBL;BindingDB
Q15125 EBP Homo sapiens Human PF05241 6.7 Ki ChEMBL;BindingDB
P08183 ABCB1 Homo sapiens Human PF00664 PF00005 6.7 Ki ChEMBL;BindingDB
P28222 HTR1B Homo sapiens Human PF00001 6.6 Ki BindingDB
P34969 HTR7 Homo sapiens Human PF00001 6.4 Ki ChEMBL;BindingDB
P35367 HRH1 Homo sapiens Human PF00001 6.4 Ki ChEMBL;BindingDB
P18089 ADRA2B Homo sapiens Human PF00001 6.3 Ki ChEMBL;BindingDB
P18825 ADRA2C Homo sapiens Human PF00001 6.3 Ki ChEMBL;BindingDB
P08913 ADRA2A Homo sapiens Human PF00001 6.2 Ki BindingDB
P07305 H1-0 Homo sapiens Human PF00538 6.1 Ki BindingDB
P20366 TAC1 Homo sapiens Human PF02202 6.0 Ki BindingDB
P21731 TBXA2R Homo sapiens Human PF00001 6.0 Ki BindingDB
P31645 SLC6A4 Homo sapiens Human PF03491 PF00209 6.0 Ki BindingDB
P35372 OPRM1 Homo sapiens Human PF00001 6.0 Ki ChEMBL
P18505 GABRB1 Homo sapiens Human PF02931 PF02932 Clinical TTD_MultiTarget TTD_MultiTarget
P32352 ERG2 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Pathogen PF04622 9.3 Ki ChEMBL;BindingDB
P04585 gag-pol Human immunodeficiency virus type 1 group M subtype B (isolate HXB2) Pathogen PF00540 PF19317 PF00552 PF02022 PF00075 PF00665 PF00077 PF00078 PF06815 PF06817 PF00098 7.0 Ki BindingDB
Q72874 pol Human immunodeficiency virus type 1 Pathogen PF00077 7.0 Ki ChEMBL
P9WFK7 eis Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Pathogen PF17668 PF13527 PF13530 6.4 IC50 ChEMBL;BindingDB
DrugBank Target Actions (32)
Target Gene Target Name Action Type
P08684 CYP3A4 Cytochrome P450 3A4 inhibitor enzymes
P10635 CYP2D6 Cytochrome P450 2D6 inhibitor enzymes
O60656 O60656 UDP-glucuronosyltransferase 1A9 substrate enzymes
P04798 CYP1A1 Cytochrome P450 1A1 substrate enzymes
P05177 CYP1A2 Cytochrome P450 1A2 substrate enzymes
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P10635 CYP2D6 Cytochrome P450 2D6 substrate enzymes
P11712 CYP2C9 Cytochrome P450 2C9 substrate enzymes
P16152 CBR1 Carbonyl reductase [NADPH] 1 substrate enzymes
P20815 CYP3A5 Cytochrome P450 3A5 substrate enzymes
P24462 CYP3A7 Cytochrome P450 3A7 substrate enzymes
P33261 CYP2C19 Cytochrome P450 2C19 substrate enzymes
P08908 HTR1A 5-hydroxytryptamine receptor 1A antagonist targets
P08913 ADRA2A Alpha-2A adrenergic receptor antagonist targets
P14416 DRD2 D(2) dopamine receptor antagonist targets
P18089 ADRA2B Alpha-2B adrenergic receptor antagonist targets
P18825 ADRA2C Alpha-2C adrenergic receptor antagonist targets
P20309 CHRM3 Muscarinic acetylcholine receptor M3 antagonist targets
P21728 DRD1 D(1A) dopamine receptor antagonist targets
P28223 HTR2A 5-hydroxytryptamine receptor 2A antagonist targets
P28335 HTR2C 5-hydroxytryptamine receptor 2C antagonist targets
P34969 HTR7 5-hydroxytryptamine receptor 7 antagonist targets
P35348 ADRA1A Alpha-1A adrenergic receptor antagonist targets
P35367 HRH1 Histamine H1 receptor antagonist targets
P50406 HTR6 5-hydroxytryptamine receptor 6 antagonist targets
Q13224 GRIN2B Glutamate receptor ionotropic, NMDA 2B antagonist targets
Q99720 SIGMAR1 Sigma non-opioid intracellular receptor 1 antagonist targets
Q05940 SLC18A2 Synaptic vesicular amine transporter inhibitor targets
Q99705 MCHR1 Melanin-concentrating hormone receptor 1 inhibitor targets
P35462 DRD3 D(3) dopamine receptor inverse agonist targets
P08183 ABCB1 ATP-dependent translocase ABCB1 inhibitor transporters
P08183 ABCB1 ATP-dependent translocase ABCB1 substrate transporters